| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/21/2002 | EP0839534B1 Pharmacological association between n-acetylcystein and levulose for preventing cellular death and related diseases |
| 08/21/2002 | EP0804456B1 Peptide nucleic acid conjugates |
| 08/21/2002 | EP0771192B1 Use of anti-vegf agents in the treatment of endometriosis |
| 08/21/2002 | EP0759757B1 Oral liquid alendronate formulations |
| 08/21/2002 | EP0756596B1 Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors |
| 08/21/2002 | EP0750501B1 Combined hormonal contraception pharmaceutical preparation |
| 08/21/2002 | EP0729358B1 Transdermal prostaglandin composition |
| 08/21/2002 | EP0696194B1 Use of indole derivatives as 5ht1 antagonists |
| 08/21/2002 | EP0683659B1 A method for stimulating hair growth with cationic derivatives of minoxidil using therapeutic iontophoresis |
| 08/21/2002 | EP0675715B1 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
| 08/21/2002 | EP0668862B1 Oxidation of glycoside substituted taxanes to taxol or taxol precursors and taxane compounds formed as intermediates |
| 08/21/2002 | EP0637203B1 Regulation of the immune system |
| 08/21/2002 | CN1365395A Tenascin-C nucleic acid liqands |
| 08/21/2002 | CN1365363A thineopyranecarboxyamide derivatives |
| 08/21/2002 | CN1365360A Puring derivatives inhibitors of tyrosine kinase SYK |
| 08/21/2002 | CN1365359A Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists |
| 08/21/2002 | CN1365356A Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect |
| 08/21/2002 | CN1365355A Quinoline derivatives as inhibitors of MEK enzymes |
| 08/21/2002 | CN1365354A Novel naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 08/21/2002 | CN1365293A Agents promoting the formation of skin basement, agents promoting the formation of artificial skin and process for producing artificial skin |
| 08/21/2002 | CN1365287A Pharmaceutical composition containing enantioners and lipase inhibitor |
| 08/21/2002 | CN1365286A Method for treating chronic HBV infection |
| 08/21/2002 | CN1365285A Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvia area |
| 08/21/2002 | CN1365284A Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 08/21/2002 | CN1365283A Unfermented gel fraction from psyllium seed husks |
| 08/21/2002 | CN1365282A Beta-carboline pharmaceutical compositions |
| 08/21/2002 | CN1365281A Metalloprotease inhibitors |
| 08/21/2002 | CN1365280A 抗菌化合物 Antibacterial compounds |
| 08/21/2002 | CN1365279A Preparations for reducing oxygen consumption during physical efforts |
| 08/21/2002 | CN1365278A Water soluble trioxanes as potent and safe anti-malarial agents |
| 08/21/2002 | CN1365277A Method for treating chronic pain using MEK inhibitors |
| 08/21/2002 | CN1365276A Method for treating eating disorders |
| 08/21/2002 | CN1364899A Mycose base hydrolase and its preparation and use |
| 08/21/2002 | CN1364642A Medicament for curing rhinitis |
| 08/21/2002 | CN1364641A Anti-drunk-enness and sobering up composition and its preparing method |
| 08/21/2002 | CN1364612A External use traditional Chinese medicine preparation for curing scald by fire or water and its preparing method |
| 08/21/2002 | CN1364609A External use medicine bag for stagnation-syndrome |
| 08/21/2002 | CN1364586A Traditional Chinese medicine compound oral sticking film for coronary heart disease and angina pectoris |
| 08/21/2002 | CN1364464A Aminoglucose hydrochloride medicinal composition |
| 08/21/2002 | CN1364463A Berberis poiretii schneid detoxicating and inflammation diminishing tablet and its preparing process |
| 08/21/2002 | CN1364462A Tinidazole colon positioning enteric soluble tablet |
| 08/21/2002 | CN1364461A Medicinal use of hypotensive and anti-tumour compound |
| 08/21/2002 | CN1364460A Dibenzo [a, KI] xanthene derivative used as anti-tumor medicine |
| 08/21/2002 | CN1364458A Controlled release hydroxy-ketone |
| 08/21/2002 | CN1364454A Method for impoving skin clean |
| 08/21/2002 | CN1364430A Method for storaging acid liquid or semiliquid composition containing kreatin for human consumption |
| 08/21/2002 | CN1364426A Production of water soluble, less water soluble or water non soluble active compound solid product |
| 08/21/2002 | CN1089340C Oxa-and thia-diazole muscarinic receptor antagonists |
| 08/21/2002 | CN1089336C Colchicine and thiocolchicine derivatives with anti-inflammatory and muscle relaxant activities |
| 08/21/2002 | CN1089248C Medicine for curing diseases in nerve system and its preparing method |
| 08/21/2002 | CN1089247C Styptic and inflammation-relieving medicine and its preparing process |
| 08/21/2002 | CN1089245C Soy extract, process for its prepn. and pharmaceutical compsn. |
| 08/21/2002 | CN1089239C Pyrimidine nucleotide precursors of treatment of animal inflammations and tissue damages |
| 08/21/2002 | CN1089238C Method for lowering cholesterol |
| 08/21/2002 | CN1089237C Compound for use in preparing medium for inhibiting vascular smooth muscle cell migration |
| 08/21/2002 | CN1089236C Medicinal composition for preventing and curing hypokalemia |
| 08/21/2002 | CN1089233C 药物组合物 The pharmaceutical composition of |
| 08/20/2002 | US6437215 SR-BI and ApoE knockout animals and use thereof as models for atherosclerosis and heart attack |
| 08/20/2002 | US6437177 α-hydroxy, -amino, and halo derivatives of β-sulfonyl hydroxamic acids as matrix metallopropteinases inhibitors |
| 08/20/2002 | US6437165 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 08/20/2002 | US6437160 3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use |
| 08/20/2002 | US6437158 Testosterone derivative |
| 08/20/2002 | US6437157 (20s)(8a,9b,13a,14b,17a) 20-(((dimethylamino)-ethyl)-amino) -19-nor-delta.sup.1,3,5(10)-pregnatrien-3-ol; acylation or alkylation of an estrone, cyanation, oximation; fertility control in males |
| 08/20/2002 | US6437156 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| 08/20/2002 | US6437148 Intermediates for (R)-3(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-a]imidazol-2-one |
| 08/20/2002 | US6437146 Mesangial proliferative glomerulonephritis |
| 08/20/2002 | US6437143 Thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same |
| 08/20/2002 | US6437138 5-bromo-6-chloro-3-(2-(s)-azetidinyl or pyrrolidinyl-methoxy) pyridine intermediates for the 5-substituted compounds which are potent ligands at neuronal nicotinic cholinergic channel receptors, neurotransmitter controlling agents |
| 08/20/2002 | US6437137 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 08/20/2002 | US6437134 Silylating the corresponding carbamate compound; alkylation |
| 08/20/2002 | US6437129 Armoatic or heteroarmoatic compound containing substituted amides or thioamides |
| 08/20/2002 | US6437125 Process for the production of purine derivatives |
| 08/20/2002 | US6437124 Xanthine derivatives which inhibit expression of adhesion molecules on human umbilical vein endothelial cell (huvec) monolayers at very low concentrations |
| 08/20/2002 | US6437005 Active topical skin protectants using polymer coated metal alloys |
| 08/20/2002 | US6437004 Treatment of skin damage using olive oil polyphenols |
| 08/20/2002 | US6437003 Use of retinoids to treat high blood pressure and other cardiovascular disease |
| 08/20/2002 | US6437000 Controlled release oral dosage for suitable for oral administration |
| 08/20/2002 | US6436999 Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them |
| 08/20/2002 | US6436998 Administering amides having improved kinetics and reduced side effects; drug abuse, drug dependence |
| 08/20/2002 | US6436997 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 08/20/2002 | US6436996 Administering exogenous sources to cells having apolipoprotein alleles, for prophylaxis of alzheimer's disease |
| 08/20/2002 | US6436995 Administering aliphatic sulfur containing amines; immunology |
| 08/20/2002 | US6436994 Administering a patient an effective amount of hydroxyeicosatetraenoic acid related compounds to treat the dry eye |
| 08/20/2002 | US6436992 Use of fumaric acid derivatives |
| 08/20/2002 | US6436990 Antiinflammatory, rheumatic and antiarthritic agents, having improved transformation; side effect reduction |
| 08/20/2002 | US6436989 Prodrugs of aspartyl protease inhibitors |
| 08/20/2002 | US6436987 Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid |
| 08/20/2002 | US6436985 Disubstituted pyrazolines and triazolines as factor Xa inhibitors |
| 08/20/2002 | US6436984 Melatonergic drugs that release nitrogen oxide and melatonin, used for prophylaxis of cardiovascular/nervous system, muscular disorders, antiischemic/inflammatory agents, reperfusion injuries, anemia and alzheimer's disease |
| 08/20/2002 | US6436983 Treatment for alzheimer's disease |
| 08/20/2002 | US6436978 For preventing or treating disorders modulated by alpha-2 adrenoceptors |
| 08/20/2002 | US6436977 Dosing regimens for lasofoxifene |
| 08/20/2002 | US6436975 Pharmaceutical compositions for ulcer |
| 08/20/2002 | US6436974 Heterocyclic amines used as antiepileptic, antiischemic, analgesic and anxiolytic agents; prophylaxis of dyskinesia, brain, nerveous system and sleep disorders |
| 08/20/2002 | US6436973 Leukotriene enzyme inhibitors, administered as antiarthritic and antiinflammatory agents; prophylaxis of psoriasis and liver disorders |
| 08/20/2002 | US6436971 Phosphodiesterase inhibitor |
| 08/20/2002 | US6436970 Compositions for the treatment of ARDS or IRDS containing 3-(cycloproplymethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamide and lung surfactant |
| 08/20/2002 | US6436969 Dialysis solutions and methods |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436966 Adenosine A3 receptor antagonists |